-
1
-
-
45849087618
-
Combination treatment with benzodiazepines and SSRls for comorbid anxiety and depression: A review
-
Dunlop, B.W., Davis, P.C., 2008. Combination treatment with benzodiazepines and SSRls for comorbid anxiety and depression: A review. Primary Care Companion to the Journal of Clinical Psychiatry 10, 222-228
-
(2008)
Primary Care Companion to the Journal of Clinical Psychiatry
, vol.10
, pp. 222-228
-
-
Dunlop, B.W.1
Davis, P.C.2
-
2
-
-
33846995166
-
What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: A replication and extension
-
Fava, M., Rush, A.J., Alp ert, J.E., Carmin, C.N., Balasubramani, G.IC, Wisniewski, SR., Trivedi, M.H., Biggs, M.M., Shores-Wilson, IC, 2006. what clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: A replication and extension. Canadian Journal of Psychiatry 51, 823-83S
-
(2006)
Canadian Journal of Psychiatry
, vol.51
, pp. 823-835
-
-
Fava, M.1
Rush, A.J.2
Alpert, J.E.3
Carmin, C.N.4
Balasubramani, G.I.C.5
Wisniewski, S.R.6
Trivedi, M.H.7
Biggs, M.M.8
Shores-Wilson, I.C.9
-
3
-
-
72949151592
-
A rating scale for depression
-
Hamilton, M., 1960. A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 23, 56-62
-
(1960)
Journal of Neurology, Neurosurgery, and Psychiatry
, vol.23
, pp. 56-62
-
-
Hamilton, M.1
-
4
-
-
57049107321
-
Concurrent anxiety and substance use disord ers among outpatients with major depression: Clinical features and effect on treatment outcome
-
Howland, RH., Rush, A.J., Wisniewski, S.R, Trivedi, M.H., Warden, D., Fava, M., Davis, I.I., Balasubramani, G.K, McGrath, P.J., Berman, SR., 2009. Concurrent anxiety and substance use disord ers among outpatients with major depression: Clinical features and effect on treatment outcome. Drug and Alcohol Dependence 99, 248-260
-
(2009)
Drug and Alcohol Dependence
, vol.99
, pp. 248-260
-
-
Howland, R.H.1
Rush, A.J.2
Wisniewski, S.R.3
Trivedi, M.H.4
Warden, D.5
Fava, M.6
Davis, I.I.7
Balasubramani, G.K.8
McGrath, P.J.9
Berman, S.R.10
-
5
-
-
0028156958
-
Lifetime and 12-month prevaLence of DSMIII-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
-
Kessler, R.C., McGonagle, KA., Zhao, S., Nelson, C.B., Hugnes, lvi., tsnie man, ., Wittchen, H.U., Kendler, KS., 1994. Lifetime and 12-month prevaLence of DSMIII-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Archives of General Psychiatry 51, 8-19
-
(1994)
Archives of General Psychiatry
, vol.51
, pp. 8-19
-
-
Kessler, R.C.1
McGonagle, K.A.2
Zhao, S.3
Nelson, C.B.4
Hugneslvitsnieman, H.5
Wittchen, U.6
Kendler, K.S.7
-
6
-
-
84857363524
-
Clinical relevance of comorbidity in anxiety disorders: A report from the Netherla nds study of depression and anxiety (NESDA
-
Klein-Hofmeijer Sevink, M., Batelaan, N.M., Van Megen, H.J.G.M., Penninx, B.W., Cath, D.C., Van Den Hout, M.A., Van Balkom, A.J.LM., 2012. Clinical relevance of comorbidity in anxiety disorders: A report from the Netherla nds study of depression and anxiety (NESDA). Journal of Affective Disorders 137, 106-112
-
(2012)
Journal of Affective Disorders
, vol.137
, pp. 106-112
-
-
Klein-Hofmeijer, H.1
Sevink, M.2
Batelaan, N.M.3
Van Megen, H.J.G.M.4
Penninx, B.W.5
Cath, D.C.6
Van Den Hout, M.A.7
Van Balkom, A.J.L.M.8
-
7
-
-
36049015484
-
Quetiapine adjunct to selective serotonin reuptake inhibitors or venl afaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: A randomized, placebo-controlled pilot study
-
Mcintyre, A., Gendron, A., Mcintyre, A., 2007. Quetiapine adjunct to selective serotonin reuptake inhibitors or venl afaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: A randomized, placebo-controlled pilot study. Depress Anxiety 24, 487-494
-
(2007)
Depress Anxiety
, vol.24
, pp. 487-494
-
-
McIntyre, A.1
Gendron, A.2
McIntyre, A.3
-
9
-
-
76649089932
-
Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: A STARD report
-
Nierenberg, A.A., Husain, M.M., Trivedi, M.H., Fava, M., Warden, D., Wisniewski, SR., Miyahara, S., Rush, A.J., 2010. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: A STARD report Psychological Medicine 40, 41-50
-
(2010)
Psychological Medicine
, vol.40
, pp. 41-50
-
-
Nierenberg, A.A.1
Husain, M.M.2
Trivedi, M.H.3
Fava, M.4
Warden, D.5
Wisniewski, S.R.6
Miyahara, S.7
Rush, A.J.8
-
10
-
-
67651155746
-
Do comorbid anxiety disorders impact treatment planning for outpatients with major depressive disorder?
-
Petersen, T., Andreotti, CE, Chelminski, L., Young, D., Zimmerman, M., 2009. Do comorbid anxiety disorders impact treatment planning for outpatients with major depressive disorder? Psychiatry Research 169, 7-11
-
(2009)
Psychiatry Research
, vol.169
, pp. 7-11
-
-
Petersen, T.1
Andreotti, C.E.2
Chelminski, L.3
Young, D.4
Zimmerman, M.5
-
11
-
-
79952240607
-
The 7-year course of depression and anxiety in the general population
-
Rhebergen, D., Batelaan, N.M., de Graaf, R., Spijker,J., Beekman, ATE, Penninx, B.W. J.H., 2011. The 7-year course of depression and anxiety in the general population. Acta Psychiatrica Scandinavica 123, 297-306
-
(2011)
Acta Psychiatrica Scandinavica
, vol.123
, pp. 297-306
-
-
Rhebergen, D.1
Batelaan, N.M.2
De Graaf, R.3
Spijker, J.4
Beekman, A.T.E.5
Penninx, B.W.J.H.6
-
12
-
-
20444455360
-
Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features
-
Rush, A.J., Zimmerman, M., Wisnie wski, SR., Fava, M., Hollon, S.D., Warden, D., Biggs, M.M., Shores-Wilson, IC, Shelton, RC, Luther, J.E, Thomas, B., Trivedi, M.H., 2000. Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features. Journal of Affective Disorders 87, 43-5S
-
(2000)
Journal of Affective Disorders
, vol.87
, pp. 43-55
-
-
Rush, A.J.1
Zimmerman, M.2
Wisniewski, S.R.3
Fava, M.4
Hollon, S.D.5
Warden, D.6
Biggs, M.M.7
Shores-Wilson, I.C.8
Shelton, R.C.9
Luther, J.E.10
Thomas, B.11
Trivedi, M.H.12
-
13
-
-
33747339984
-
Report by the ACNP task force on response and remission in major depressive disorder
-
ACNP Task Force
-
Rush, A.J., Kraemer, H.C., Sackeim, H.A., Fava, M., Trivedi, M.H., Frank, E., Ninan, PT., Thase, M.E., Gelenberg, A.J., Kupfer , D.J., Regier, D.A., Rosenbaum, J.E, Ray, O., Schatzberg, A.E, 2006. ACNP Task Force. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology 31, 1841-1853
-
(2006)
Neuropsychopharmacology
, vol.31
, pp. 1841-1853
-
-
Rush, A.J.1
Kraemer, H.C.2
Sackeim, H.A.3
Fava, M.4
Trivedi, M.H.5
Frank, E.6
Ninan, P.T.7
Thase, M.E.8
Gelenberg, A.J.9
Kupfer, D.J.10
Regier, D.A.11
Rosenbaum, J.E.12
Ray, O.13
Schatzberg, A.E.14
-
14
-
-
27744599324
-
Anxiety disorders and risk for suicidal ideation and suicide attempts: A population-based longitudinal study of adults
-
Sareen, J., Cox, B.J., Afifi, TO., de Graaf, R, Asmundson, G.J.G., ten Have, M., Stein, M.B., 2005. Anxiety disorders and risk for suicidal ideation and suicide attempts: A population-based longitudinal study of adults. Archives of General Psychiatry 62, 1249-1257
-
(2005)
Archives of General Psychiatry
, vol.62
, pp. 1249-1257
-
-
Sareen, J.1
Cox, B.J.2
Afifi, T.O.3
De Graaf, R.4
Asmundson, G.J.G.5
Ten Have, M.6
Stein, M.B.7
-
15
-
-
0142043014
-
Evaluating antidepressant therapies: Remission as the optimal outcome
-
Thase, M., 2003. Evaluating antidepressant therapies: Remission as the optimal outcome. Journal of Clinical Psychiatry 64, 18-2S
-
(2003)
Journal of Clinical Psychiatry
, vol.64
, pp. 18-25
-
-
Thase, M.1
-
16
-
-
0033847079
-
Frequency of anxiety disorders in psychiatric outpatients with major depressive disorder
-
Zimmerman, M., McDermut, W., Mattia, J.I., 2000. Frequency of anxiety disorders in psychiatric outpatients with major depressive disorder. American Journal of Psychiatry 157, 1337-1340
-
(2000)
American Journal of Psychiatry
, vol.157
, pp. 1337-1340
-
-
Zimmerman, M.1
McDermut, W.2
Mattia, J.I.3
-
17
-
-
0346887198
-
The diagnostic inventory for depression: A self-report scale to diagnose for DSM-1V major depressive disorder
-
Zimmerman, M., Sheeran, T., Young, D., 2004. The diagnostic inventory for depression: A self-report scale to diagnose for DSM-1V major depressive disorder. Journal of Clinical Psychology 60, 87-110
-
(2004)
Journal of Clinical Psychology
, vol.60
, pp. 87-110
-
-
Zimmerman, M.1
Sheeran, T.2
Young, D.3
-
18
-
-
33846804489
-
Heterogeneity among depressed outpatients considered to be in remission
-
Zimmerman, M., Posternak, M.A., Chelminski, L., 2007. Heterogeneity among depressed outpatients considered to be in remission. Comprehensive Psychiatry 48, 113-117
-
(2007)
Comprehensive Psychiatry
, vol.48
, pp. 113-117
-
-
Zimmerman, M.1
Posternak, M.A.2
Chelminski, L.3
-
19
-
-
38549136565
-
A clinically useful depression outcome scale
-
Zimmerman, M., Chelminski, L., McGlinchey, J.B., Posternak, M.A., 2008. A clinically useful depression outcome scale. Comprehensive Psychiatry 49, 131-140
-
(2008)
Comprehensive Psychiatry
, vol.49
, pp. 131-140
-
-
Zimmerman, M.1
Chelminski, L.2
McGlinchey, J.B.3
Posternak, M.A.4
-
20
-
-
77952590925
-
A clinically useful anxiety outcome scale
-
Zimmerman, M., Chelminski, L., Young, D., Dalrymple, IC, 2010. A clinically useful anxiety outcome scale. Journal of Clinical Psychiatry 71, 534-542
-
(2010)
Journal of Clinical Psychiatry
, vol.71
, pp. 534-542
-
-
Zimmerman, M.1
Chelminski, L.2
Young, D.3
Dalrymple, I.C.4
-
21
-
-
84872798589
-
How should residual symptoms be defined in depressed patients who have remitted?
-
Zimmerman, M., Martinez, J., Attiullah, N., Friedman, M., Toba, C., Boerescu, D., 2013. How should residual symptoms be defined in depressed patients who have remitted? Comprehensive Psychiatry, 91-96
-
(2013)
Comprehensive Psychiatry
, pp. 91-96
-
-
Zimmerman, M.1
Martinez, J.2
Attiullah, N.3
Friedman, M.4
Toba, C.5
Boerescu, D.6
|